| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | February 23, 2026 4:30 P.M. |
| Form: | F-3 | ||||||
| |||||||
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
3 - iTonic Holdings Ltd (0001970544) (Issuer)
3 - iTonic Holdings Ltd (0001970544) (Issuer)
3 - iTonic Holdings Ltd (0001970544) (Issuer)
6-K - iTonic Holdings Ltd (0001970544) (Filer)
20-F/A - iTonic Holdings Ltd (0001970544) (Filer)
20-F - iTonic Holdings Ltd (0001970544) (Filer)
BEIJING, China, April 23, 2026 (GLOBE NEWSWIRE) -- iTonic Holdings Ltd (the "Company" or "ITOC"), a healthcare solution provider specializing in treatment planning systems for brachytherapy and other related products and services, today announced that on April 21, 2026, it received notification from The Nasdaq Stock Market LLC ("Nasdaq") that Nasdaq approved the Company's request for an extension of additional 180-calendar day, or until October 19, 2026 (the "Extension") to regain compliance with the minimum closing bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) (the "Minimum Bid Price Rule").The Extension follows the expiration the initial 180-calendar day compliance p